Biocure Technology Management
Management criteria checks 2/4
Biocure Technology's CEO is Simon Cheng, appointed in Sep 2023, has a tenure of 1.25 years. directly owns 0.006% of the company’s shares, worth CA$87.56. The average tenure of the management team and the board of directors is 4.8 years and 6.8 years respectively.
Key information
Simon Cheng
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.006% |
| Management average tenure | 4.8yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO
Simon Cheng (43 yo)
1.3yrs
Tenure
Mr. Yee Sing Cheng, also known as Simon, serves as CEO & Director at Biocure Technology Inc. since September 2023. He is Director of ALDD Ventures Corp. from February 2023. He serves as CEO and Director at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.4yrs | CA$5.91k | no data | |
| CFO, Corporate Secretary & Director | 6.8yrs | CA$60.00k | 0.32% CA$ 4.5k | |
| CEO & Director | 1.3yrs | no data | 0.0062% CA$ 87.6 | |
| Consultant | 6.3yrs | CA$16.50k | no data |
4.8yrs
Average Tenure
Experienced Management: CURE.X's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO, Corporate Secretary & Director | 6.8yrs | CA$60.00k | 0.32% CA$ 4.5k | |
| CEO & Director | 1.3yrs | no data | 0.0062% CA$ 87.6 | |
| Independent Director | 9.3yrs | CA$60.00k | 0.42% CA$ 5.9k | |
| Member of Advisory Board | 6.8yrs | no data | no data | |
| Member of Advisory Board | 6.8yrs | no data | no data | |
| Member of Advisory Board | 6.8yrs | no data | no data |
6.8yrs
Average Tenure
43yo
Average Age
Experienced Board: CURE.X's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 19:03 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biocure Technology Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|